New eye injection shows promise for blinding disease
Disease control
Recruiting now
This early-stage study tests the safety of a new drug called BBC1501, given as an injection into the eye, for people with wet age-related macular degeneration (nAMD). The trial involves 18 adults aged 50 and older who have already received standard treatment. The main goal is to …
Phase: PHASE1 • Sponsor: Benobio Co., Ltd. • Aim: Disease control
Last updated Jun 16, 2026 23:34 UTC